Patients without diabetes who switched GLP-1 receptor agonist (GLP-1RA) drugs for overweight or obesity were more likely to stick with their treatment longer than those who didn't switch, according to a new study by UT Southwestern ...
2 hours ago
0
0
The drugs have names that sound like small planets: semaglutide, liraglutide, lixisenatide. Collectively, they belong to a class of glucagon-like peptide 1 (GLP-1) analogs that has reshaped the treatment of obesity and diabetes ...
20 hours ago
0
0
Researchers from the University of Southern Denmark investigated how eight weeks of high-intensity interval training affect the structure of mitochondria—the parts of muscle cells that produce energy. The study shows that ...
Mar 9, 2026
0
0
A new study from researchers led by Johns Hopkins Medicine reports substantial new evidence that elevated blood biomarkers of subclinical heart injury or stress—heart muscle damage without symptoms of a heart attack—are ...
Mar 9, 2026
0
0
Northwestern Medicine scientists led by Joseph Bass, MD, Ph.D., the Charles F. Kettering Professor of Endocrinology and Metabolism and director of the Center for Diabetes and Metabolism, have discovered how disruptions in ...
Mar 9, 2026
0
0
Type 1 diabetes (T1D) is an autoimmune condition in which the body's own immune system attacks insulin-producing cells. As a result, patients with T1D must closely monitor their blood glucose (BG) levels and rely on insulin ...
Mar 9, 2026
0
0
Women with certain cardiometabolic risk factors, including type 2 diabetes and high waist circumference, face a greater increase in risk for liver fibrosis than men with the same risk factors. The study, just published in ...
Mar 9, 2026
0
0
The beta cells in our pancreas act as highly sensitive sensors that constantly measure the amount of sugar in our blood. As soon as we eat something and the sugar level rises, the beta cells produce insulin to help the body ...
Mar 8, 2026
0
0
Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) for type 2 diabetes and obesity is independently associated with a significantly increased five-year risk for osteoporosis, gout, and osteomalacia compared ...
Mar 6, 2026
0
0
Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, according to a small new study.
Mar 6, 2026
0
1
